hg_236043.1

Basic information about the TSS

---

TSS ID: hg_236043.1 Species: human Chr: chr16		Start: 31095991 End: 31096003 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000498155.1 Distance: 12 GeneID: 79001 HGNC/MGI_ID: HGNC:23663 UniProt_ID: F2Z3Q2

Gene_name: vitamin K epoxide reductase complex subunit 1 Gene_symbol: VKORC1 Gene_synonyms: Gene_source: HGNC:23663

TATA-Box annotation

---

Distance to TSS:	-16
Nearest PromoterID:	NM_001135865
Entrez ID:	100132247
Nearest Unigene:	Hs.611072
Nearest Refseq:	NM_001135865
Nearest Ensembl:	ENSG00000243716
Gene Name:	vitamin K epoxide reductase complex subunit 1
Gene Alias:	-
Gene Description:	nuclear pore complex interacting protein family member B5
Gene Type:	protein-coding
CpG%:	0.01
GC%:	0.318408
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@VKORC1 p2@VKORC1 p3@VKORC1 p4@VKORC1 p5@VKORC1
Sample		p1@VKORC1	p2@VKORC1	p3@VKORC1	p4@VKORC1	p5@VKORC1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	22.99	31.17	5.84	16.17	1.36
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	29.74	25.09	4.25	18.21	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	27.20	32.02	5.02	17.55	1.54
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	25.78	32.85	6.24	19.54	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	24.97	35.77	5.17	19.35	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	23.64	39.15	6.20	16.67	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	34.21	56.21	8.50	20.05	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	33.18	49.90	6.06	18.65	2.18
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	29.71	47.45	7.69	21.80	1.71
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.91	26.66	4.64	6.96	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	9.70	30.32	4.85	10.51	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	13.42	26.02	2.85	7.72	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	221.80	31.92	16.44	5.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	208.99	30.67	17.89	3.91	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	182.01	29.20	12.95	2.63	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	192.89	28.42	14.08	4.02	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	195.69	37.57	14.63	1.09	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	194.46	38.81	13.92	3.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	190.34	51.18	11.20	6.40	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	234.84	35.81	18.35	4.21	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	225.20	33.81	19.11	3.21	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	217.85	34.87	15.71	2.93	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	180.70	32.57	12.02	3.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	182.73	32.03	18.20	2.91	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	186.27	34.05	13.42	3.35	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	204.15	30.07	13.29	2.85	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	189.56	46.15	12.64	2.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	223.97	33.24	16.03	2.36	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	255.69	37.47	20.84	3.88	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	203.77	28.77	16.11	3.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	190.29	33.91	12.98	2.72	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	209.45	33.80	16.22	4.10	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	247.96	39.67	16.04	2.95	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	256.65	48.82	19.96	2.64	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	200.08	29.54	13.46	4.49	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	200.63	25.87	12.84	3.07	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	209.08	28.82	15.12	2.86	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	175.29	32.84	14.10	2.22	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	193.12	23.23	10.26	2.43	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	163.24	25.69	11.52	3.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	193.38	29.88	15.29	1.18	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	201.29	33.09	15.52	2.78	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	160.49	26.36	9.49	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	180.42	24.65	11.89	2.45	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	170.05	19.88	11.85	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	169.60	20.94	10.93	2.33	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	165.06	26.15	11.52	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	187.47	20.27	15.80	1.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	182.64	21.06	11.49	1.91	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	192.90	22.24	15.77	2.02	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	163.35	33.20	12.71	3.28	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	195.24	25.57	9.34	3.34	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	13.99	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	172.11	29.45	8.87	3.19	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	157.41	19.55	13.59	5.30	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	140.10	32.72	7.55	5.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	190.13	39.04	13.78	4.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	177.94	19.45	6.48	4.54	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	165.40	21.20	9.64	2.25	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	212.49	34.26	13.52	4.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	143.83	13.40	12.69	1.41	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	140.76	15.70	14.58	5.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	164.01	22.29	7.17	4.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	167.85	27.52	10.87	3.40	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	124.77	16.57	6.17	4.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	139.15	20.23	8.52	3.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	110.56	31.59	15.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	134.55	40.46	10.24	3.41	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	149.75	39.17	13.39	4.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	166.07	41.28	11.26	3.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	184.14	41.07	12.59	3.31	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	188.39	34.96	17.01	6.50	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	175.80	34.85	16.20	1.22	0.00
Adipocyte - breast, donor1	11376-118A8	227.91	67.47	18.53	0.63	0.32
Adipocyte - breast, donor2	11327-117E4	166.04	33.85	11.07	3.37	0.64
Adipocyte - omental, donor1	11473-119C6	246.57	72.77	22.01	1.02	0.13
Adipocyte - omental, donor2	11474-119C7	224.25	44.85	9.72	2.24	1.49
Adipocyte - omental, donor3	11475-119C8	236.79	47.89	10.72	4.02	0.33
Adipocyte - perirenal, donor1	11476-119C9	395.55	100.16	22.97	5.10	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	104.45	42.88	17.59	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	187.88	88.97	32.07	1.81	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	161.09	41.53	12.51	1.04	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	128.30	23.47	10.37	0.78	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	83.39	22.91	6.95	2.06	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	80.57	25.93	6.97	0.56	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	65.83	24.10	6.47	1.76	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	71.26	15.85	4.67	0.40	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	69.39	20.66	4.20	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	66.65	21.33	3.20	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	52.86	26.15	7.79	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	75.28	24.54	5.41	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	79.87	25.87	6.28	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	50.40	16.69	4.91	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	32.88	14.01	3.04	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	105.64	42.21	11.49	8.18	1.77
Alveolar Epithelial Cells, donor2	11590-120G6	165.66	49.13	12.55	15.06	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	197.67	47.92	14.38	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	59.01	14.21	6.12	16.73	1.98
Amniotic Epithelial Cells, donor2	11613-122A2	71.96	36.82	6.69	26.78	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	70.47	27.53	5.14	11.71	3.08
Anulus Pulposus Cell, donor1	11248-116E6	152.30	26.78	7.44	1.26	0.11
Anulus Pulposus Cell, donor2	11463-119B5	151.35	21.06	4.90	1.96	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	93.00	26.51	6.29	1.80	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	90.30	26.48	9.55	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	98.45	32.10	12.84	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	87.58	25.11	10.16	1.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	86.00	21.50	3.79	7.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	87.79	29.70	5.28	3.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	79.92	22.09	10.72	1.95	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	105.34	21.36	8.25	2.43	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	92.65	27.91	6.53	2.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	93.03	24.86	9.42	2.64	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	101.59	26.85	8.71	0.73	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	89.02	23.82	7.52	3.76	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	108.40	29.65	10.54	1.98	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	109.18	23.20	6.82	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	128.47	26.09	10.10	1.66	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	100.19	23.57	4.82	2.68	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	107.50	25.51	10.01	1.89	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	93.55	28.87	9.89	2.94	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	93.64	23.41	10.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	95.70	23.05	8.62	1.99	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	91.25	28.82	6.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	84.96	38.94	14.16	17.70	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	91.77	24.19	9.95	1.72	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	109.07	16.78	8.39	12.58	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	92.72	21.36	14.56	1.94	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	110.04	30.74	7.59	2.28	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	98.12	27.86	14.54	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	90.64	19.38	8.55	2.28	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	98.55	28.43	7.91	2.57	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	113.82	28.91	7.48	3.87	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	111.67	30.50	9.38	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	108.04	26.05	13.18	2.89	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	96.32	27.11	14.98	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	74.29	32.76	8.19	1.75	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	96.95	25.89	10.24	3.01	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	128.30	36.83	5.94	5.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	105.78	28.48	11.19	2.03	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	100.86	28.78	9.68	2.80	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	121.36	38.76	12.07	2.54	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	91.49	26.32	8.20	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	102.03	24.34	7.41	2.12	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	105.84	34.22	6.38	2.03	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	82.19	25.51	6.61	3.78	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	104.94	24.92	8.14	1.86	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	94.97	37.06	6.95	4.63	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	105.63	25.35	4.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	103.78	22.08	6.86	3.22	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	116.72	30.08	7.22	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	85.29	28.43	7.29	5.10	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	108.73	25.75	10.57	4.37	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	86.71	25.50	10.20	5.10	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	144.15	31.52	12.71	2.29	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	109.83	30.76	8.26	1.86	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	112.00	25.09	7.96	2.45	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	93.21	23.42	12.91	2.87	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	102.89	21.51	10.20	2.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	134.27	30.52	9.15	6.10	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	98.04	25.48	9.42	1.66	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	97.71	20.39	10.59	1.85	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	102.13	28.35	6.54	1.82	0.73
Astrocyte - cerebellum, donor1	11500-119F6	142.96	36.84	7.12	4.42	1.60
Astrocyte - cerebellum, donor2	11580-120F5	165.00	35.26	8.56	4.28	0.34
Astrocyte - cerebellum, donor3	11661-122F5	114.31	28.53	10.28	2.10	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	78.08	14.29	7.67	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	71.02	17.63	7.60	3.88	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	91.44	20.29	5.67	2.24	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	32.69	49.89	4.13	2.06	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	25.43	45.35	2.38	1.75	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	22.30	41.88	3.64	2.73	0.34
Basophils, donor1	12241-129G9	17.00	17.52	2.35	0.26	0.00
Basophils, donor2	12242-129H1	11.91	17.68	1.80	0.36	0.00
Basophils, donor3	12243-129H2	21.31	10.14	1.03	0.59	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	33.20	29.97	3.88	4.74	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	119.33	49.38	9.14	8.69	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	35.87	7.17	7.17	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	60.25	19.46	6.28	6.28	3.77
Bronchial Epithelial Cell, donor5	11457-119A8	52.40	18.72	6.86	6.03	1.25
Bronchial Epithelial Cell, donor6	11461-119B3	29.02	9.67	1.84	2.30	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	30.41	25.01	4.68	2.52	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	6.08	47.82	3.71	0.31	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	32.84	54.27	7.69	6.29	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	79.30	70.03	19.83	1.28	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	62.05	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	16.91	9.02	3.38	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	11.14	7.61	0.74	0.56	0.00
CD14+ Monocytes, donor3	11381-118B4	12.95	10.32	1.10	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	80.67	26.89	7.36	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	74.30	26.16	4.93	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	86.46	24.98	5.26	0.99	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	14.02	10.55	1.30	0.29	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	12.37	9.35	0.60	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	11.13	9.71	0.71	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	8.04	8.87	1.84	0.67	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	11.32	7.18	1.38	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	7.93	14.13	1.98	0.74	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	8.42	6.07	2.35	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	9.26	6.23	1.07	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.76	8.49	0.87	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	6.56	7.49	0.94	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	4.22	5.81	0.00	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	9.98	9.98	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	11.45	9.52	2.53	0.45	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	8.58	12.37	2.20	0.60	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	13.53	16.66	2.91	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	8.47	8.69	0.69	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	8.82	10.63	2.04	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	8.29	12.22	1.75	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	8.61	8.34	0.54	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	12.04	9.07	2.09	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	9.26	6.73	0.84	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	6.61	3.67	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	5.64	4.23	2.11	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.51	5.70	0.00	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	16.04	10.29	0.87	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	12.64	5.95	1.86	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	14.87	13.15	1.29	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	10.65	3.69	0.41	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	8.81	4.87	0.46	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.96	4.87	1.39	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	24.19	28.55	4.14	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	26.80	23.33	3.46	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	23.39	21.01	3.03	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	48.90	26.32	3.89	0.47	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	42.79	20.61	2.79	0.52	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	24.97	17.17	2.90	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	22.97	28.83	3.83	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	15.81	27.23	1.98	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	16.63	25.05	2.74	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	91.45	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.68	65.76	0.68	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	1.04	63.17	1.04	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	9.59	81.55	3.20	1.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	4.29	65.40	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	5.62	53.35	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	4.71	70.59	2.35	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	2.64	71.19	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.00	23.84	0.82	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	1.45	9.43	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	2.02	20.19	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	16.57	36.37	5.25	3.23	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	17.18	33.96	2.00	4.39	0.40
CD34+ Progenitors, donor1	11545-120B6	33.13	20.08	7.03	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	15.73	13.48	2.25	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	76.65	44.34	10.90	3.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	84.33	67.87	16.01	3.61	0.45
CD4+ T Cells, donor1	11225-116C1	4.28	20.00	2.14	0.71	0.00
CD4+ T Cells, donor2	11306-117C1	6.74	24.49	0.61	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	3.96	27.75	2.74	0.91	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	6.38	105.67	2.81	1.02	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	8.53	103.54	2.47	0.90	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	8.34	96.30	2.59	1.44	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	6.16	71.59	1.90	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	7.02	78.66	4.92	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	95.59	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	8.38	80.78	2.89	0.58	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	11.52	89.82	2.88	0.51	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	9.03	77.06	3.06	1.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	4.93	76.66	2.24	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	6.99	80.71	2.10	0.70	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	7.48	84.92	1.32	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	11.38	87.70	2.95	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	16.62	67.11	3.32	0.83	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	13.03	75.18	2.34	1.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	7.34	65.81	2.45	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	9.65	53.06	2.68	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	10.76	62.76	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	10.94	98.46	1.85	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	13.21	100.29	3.25	0.65	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	7.36	100.45	2.94	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	8.60	88.48	5.56	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	13.00	77.12	6.50	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	7.84	68.86	0.87	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	10.39	109.86	2.97	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	8.31	90.47	4.62	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	9.77	136.79	4.19	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	14.68	102.19	2.49	0.83	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	13.74	109.44	4.17	0.49	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	10.78	115.50	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	12.53	119.61	3.22	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	5.54	141.27	5.54	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	2.29	39.29	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	5.26	23.65	0.38	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	5.30	28.78	0.25	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	17.20	23.40	4.13	8.72	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.26	27.32	1.68	5.27	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	15.32	26.26	3.56	6.02	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	18.91	27.32	1.80	9.61	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	18.48	29.04	3.60	12.00	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	13.64	23.42	2.96	9.32	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	15.43	24.12	3.04	9.56	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	15.27	21.32	1.84	9.48	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	18.29	18.06	3.05	12.66	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	17.81	29.89	4.23	7.55	2.42
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	16.27	21.50	2.61	9.88	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	12.26	22.38	2.93	6.66	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	13.57	17.51	0.88	7.00	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	8.65	19.58	2.28	14.12	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	5.22	13.43	2.24	11.19	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	15.13	26.29	3.24	12.97	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	13.52	20.14	3.16	7.77	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	12.73	25.22	2.83	8.72	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	19.96	21.87	6.34	11.41	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	21.84	15.99	4.92	11.38	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	15.07	21.16	4.17	10.90	2.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	17.59	22.95	4.59	6.50	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	14.58	16.55	3.94	9.06	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	14.37	19.67	3.03	5.29	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	8.83	19.27	3.21	26.50	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	5.60	28.68	0.70	18.88	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	7.01	17.03	1.00	23.04	1.00
Cardiac Myocyte, donor1	11525-119I4	43.87	7.31	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	90.42	7.41	4.45	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	167.74	20.20	9.47	5.37	1.37
Chondrocyte - de diff, donor1	11261-116G1	209.39	42.99	18.72	1.73	0.35
Chondrocyte - de diff, donor2	11338-117F6	135.04	34.47	10.66	1.78	0.00
Chondrocyte - de diff, donor3	11410-118E6	173.40	30.95	18.43	2.05	0.11
Chondrocyte - re diff, donor2	11339-117F7	347.36	103.85	56.40	5.37	2.69
Chondrocyte - re diff, donor3	11411-118E7	544.33	91.80	48.53	7.68	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	91.81	23.41	6.08	1.95	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	102.39	19.03	5.56	2.57	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	84.78	15.31	5.84	2.39	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	72.99	35.30	9.45	1.56	0.09
Corneal Epithelial Cells, donor1	11526-119I5	44.79	24.37	4.61	5.93	0.66
Corneal Epithelial Cells, donor2	11606-120I4	27.30	17.06	3.41	6.83	2.28
Corneal Epithelial Cells, donor3	11687-122I4	48.57	19.94	3.58	5.11	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	57.62	18.00	4.79	0.66	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	55.83	21.76	3.78	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	65.56	3.45	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	56.26	18.47	5.62	0.54	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	17.08	31.77	2.73	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	28.07	39.83	3.26	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	14.03	35.33	2.42	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	51.70	18.34	7.50	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	52.81	21.12	4.11	1.17	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	83.14	27.15	9.05	1.13	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	52.29	8.26	5.11	0.79	0.39
Endothelial Cells - Artery, donor1	11264-116G4	54.39	22.98	3.78	2.62	0.00
Endothelial Cells - Artery, donor2	11341-117F9	61.17	26.12	5.65	0.94	0.47
Endothelial Cells - Artery, donor3	11413-118E9	72.75	25.07	8.77	0.18	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	91.54	27.71	5.10	0.66	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	93.71	20.39	4.26	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	69.35	28.19	5.64	0.85	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	77.55	23.18	4.46	0.89	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	46.86	28.12	5.73	1.56	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	63.38	15.45	3.69	1.70	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	84.43	25.61	7.20	1.60	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	77.57	19.92	4.72	1.05	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	84.86	24.73	6.83	0.62	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	53.23	8.47	2.82	0.43	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	53.74	12.21	4.52	0.49	0.12
Endothelial Cells - Vein, donor1	11267-116G7	54.60	14.79	4.55	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	55.18	16.07	5.59	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	81.49	23.39	5.34	2.20	0.31
Eosinophils, donor1	12244-129H3	0.00	15.25	30.49	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	21.45	0.00	3.30	0.00
Eosinophils, donor3	12246-129H5	3.57	60.64	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	51.06	18.81	3.18	5.62	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	39.52	41.60	6.24	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	32.54	0.00	32.54	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	272.58	59.94	25.04	4.11	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	178.90	39.63	18.50	8.65	1.31
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	71.61	24.05	7.80	5.42	0.98
Fibroblast - Aortic Adventitial, donor1	11245-116E3	99.33	24.26	8.97	2.06	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	94.85	23.61	10.24	2.73	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	133.84	20.99	10.76	2.00	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	191.29	36.36	9.49	2.90	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	100.32	24.91	8.30	2.99	0.66
Fibroblast - Cardiac, donor1	11268-116G8	109.32	26.76	11.79	6.35	0.45
Fibroblast - Cardiac, donor2	11345-117G4	87.16	19.71	11.37	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	146.99	35.17	14.04	3.79	1.73
Fibroblast - Cardiac, donor4	11452-119A3	93.66	10.91	5.46	1.21	0.00
Fibroblast - Cardiac, donor5	11456-119A7	79.95	16.24	2.66	1.14	0.25
Fibroblast - Cardiac, donor6	11460-119B2	82.32	15.77	4.24	1.97	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	181.96	26.26	5.76	3.75	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	100.09	13.37	3.45	4.31	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	95.21	35.16	2.93	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	92.72	31.83	14.99	10.38	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	140.43	17.98	4.75	3.05	0.68
Fibroblast - Dermal, donor1	11269-116G9	75.13	21.13	5.63	3.76	0.47
Fibroblast - Dermal, donor2	11346-117G5	51.88	30.66	7.55	2.83	0.00
Fibroblast - Dermal, donor3	11418-118F5	100.94	20.07	9.19	3.99	0.24
Fibroblast - Dermal, donor4	11450-119A1	98.46	25.32	7.01	5.99	1.02
Fibroblast - Dermal, donor5	11454-119A5	81.12	19.71	6.28	5.58	0.70
Fibroblast - Dermal, donor6	11458-119A9	87.71	24.69	7.31	6.17	0.97
Fibroblast - Gingival, donor1	11237-116D4	98.70	20.41	7.70	1.46	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	131.52	23.84	7.07	3.14	0.26
Fibroblast - Gingival, donor2	11318-117D4	105.56	23.46	6.59	6.46	1.05
Fibroblast - Gingival, donor3	11394-118C8	86.53	16.92	4.74	1.06	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	108.04	16.62	5.19	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	100.61	17.44	6.70	1.06	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	107.26	21.67	5.77	5.30	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	95.74	22.72	7.98	2.30	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	55.40	11.29	5.29	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	139.08	21.94	7.46	2.49	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	129.13	28.23	9.54	4.36	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	105.42	22.93	9.54	3.62	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	167.58	24.21	11.74	1.17	0.15
Fibroblast - Lung, donor1	11270-116H1	47.58	12.23	4.08	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	67.15	23.87	5.97	2.98	1.49
Fibroblast - Lung, donor3	11419-118F6	110.58	25.11	10.34	2.53	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	205.76	35.82	14.99	5.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	137.07	16.78	2.80	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	138.26	32.47	9.52	1.40	0.56
Fibroblast - Mammary, donor1	11540-120B1	139.25	34.51	7.31	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	127.81	55.92	7.99	7.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	190.60	29.78	17.87	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	97.57	19.59	8.34	7.18	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	88.28	24.12	6.98	4.25	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	72.82	15.61	6.12	2.14	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	84.72	20.23	5.34	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	133.38	22.14	9.72	1.89	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	116.79	15.89	6.73	0.58	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	108.10	27.52	10.06	3.98	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	115.41	20.12	5.49	4.47	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	86.20	26.73	6.68	4.01	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	115.05	23.72	7.12	2.77	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	117.28	29.97	5.95	3.77	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	209.23	37.83	14.92	2.31	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	191.76	37.05	15.37	3.55	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	177.50	30.99	8.12	2.41	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	177.15	27.53	8.74	3.78	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	106.80	26.32	5.57	3.54	0.51
Fibroblast - skin normal, donor1	11553-120C5	215.27	45.12	16.57	3.12	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	184.47	31.88	12.23	3.41	0.40
Fibroblast - skin normal, donor2	11561-120D4	185.45	30.64	9.74	2.51	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	98.53	25.99	5.74	3.63	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	195.93	31.90	11.85	1.82	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	178.99	27.01	6.67	2.39	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	221.69	45.00	15.76	3.28	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	236.90	43.03	15.13	3.41	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	141.52	32.72	11.98	5.40	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	294.66	64.14	17.88	8.15	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	66.48	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	16.56	25.27	5.23	6.10	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	31.03	18.55	1.91	4.51	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	37.73	18.22	2.34	7.55	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	24.78	17.63	1.53	3.58	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	71.20	49.76	19.90	15.31	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	67.64	61.89	18.50	17.23	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	104.12	71.89	22.54	8.27	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	82.18	27.58	15.17	1.65	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	69.41	36.30	10.73	4.57	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	96.89	54.68	19.42	4.95	1.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	79.56	26.17	10.57	3.97	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	57.40	21.53	7.18	5.54	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	88.89	96.85	28.74	9.73	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	69.25	46.21	17.38	6.36	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	51.23	32.14	10.59	4.31	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	61.78	44.32	14.51	9.13	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	63.43	33.95	8.92	1.36	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	55.79	27.96	8.31	3.88	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	42.49	27.24	7.12	4.88	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	66.17	38.56	8.67	1.83	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	57.55	25.16	6.85	2.74	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	52.46	33.01	6.12	3.06	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	90.12	45.80	9.75	2.66	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	63.58	27.50	9.06	3.18	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	55.18	25.69	7.15	2.68	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	77.83	41.13	8.27	4.23	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	63.79	31.72	10.01	2.54	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	69.78	34.14	7.18	2.22	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	124.14	62.02	12.17	1.87	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	106.39	55.50	12.30	3.24	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	69.71	33.31	9.74	1.77	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	80.70	36.19	9.40	2.83	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	67.99	39.82	7.96	3.47	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	88.71	48.07	12.79	2.48	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	78.28	33.32	7.15	2.65	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	83.72	36.69	7.50	2.33	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	78.25	44.31	8.38	2.65	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	68.38	38.37	9.72	1.23	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	78.78	36.80	9.08	4.05	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	90.76	57.41	8.98	2.57	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	82.15	44.44	12.89	2.65	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	97.59	41.92	12.50	1.11	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	86.06	51.69	9.43	3.04	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	68.26	47.25	11.92	1.99	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	96.60	39.96	12.73	1.32	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	62.84	57.23	14.03	1.96	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	48.24	25.00	6.76	1.30	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	68.46	34.50	5.08	1.60	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	61.36	36.11	6.89	2.45	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	56.74	26.68	9.84	0.91	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	76.98	25.48	6.23	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	87.75	37.61	7.74	3.13	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	90.58	47.37	8.77	1.32	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	79.34	30.74	3.97	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	104.61	35.22	6.33	1.58	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	113.59	40.15	7.87	1.01	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	109.29	58.20	10.42	0.25	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	62.90	64.89	12.74	8.16	1.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	41.91	36.52	9.55	2.77	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	44.80	46.03	18.21	5.11	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	106.71	69.47	30.98	21.28	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	94.09	59.90	23.73	17.52	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	56.27	34.59	11.99	15.68	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	71.77	42.07	14.85	27.22	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	57.25	30.94	13.15	8.12	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	70.60	57.76	9.63	20.86	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	64.34	22.60	15.65	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	61.84	29.94	9.44	9.11	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	53.12	31.30	9.47	7.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	29.99	3.33	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	58.45	26.57	8.11	6.43	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	62.43	27.13	10.46	5.88	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	72.14	24.33	12.58	4.19	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	73.16	33.72	9.22	3.18	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	75.07	36.00	10.19	5.09	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	100.23	43.85	10.44	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	101.37	41.81	8.59	5.15	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	89.09	46.47	9.47	5.03	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	81.32	25.41	10.16	8.47	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	85.74	31.89	5.80	5.38	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	74.79	31.99	7.36	3.22	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	105.37	31.61	10.54	21.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	67.66	27.29	7.69	4.61	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	83.45	32.27	7.50	4.89	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	123.74	33.44	8.03	5.35	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	77.82	36.99	12.33	5.01	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	69.84	26.70	5.48	3.77	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	62.12	27.33	0.00	7.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	83.05	38.22	8.97	4.25	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	105.61	30.17	5.43	3.02	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	91.56	27.98	11.19	4.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	85.75	35.50	8.77	5.18	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	89.30	37.99	7.40	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	86.17	31.87	9.44	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	105.60	36.76	7.00	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	78.56	32.48	3.95	2.19	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	65.27	22.04	4.24	3.39	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	74.02	29.25	3.58	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	82.01	28.63	5.82	7.28	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	102.72	34.24	12.55	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	183.79	37.84	14.14	4.57	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	124.81	30.36	10.12	5.62	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	108.79	25.37	7.29	1.59	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	193.00	35.93	18.80	4.60	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	127.41	45.26	14.04	24.25	3.60
Hep-2 cells mock treated, biol_rep2	11899-125E9	107.70	45.91	15.02	28.53	2.87
Hep-2 cells mock treated, biol_rep3	11900-125F1	116.25	43.23	15.47	21.61	2.73
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	128.00	50.39	14.10	23.94	2.62
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	126.58	46.64	16.98	28.15	2.79
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	111.30	44.99	15.29	22.60	2.80
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	135.75	51.31	16.56	20.05	2.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	113.05	37.40	16.13	26.76	1.54
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	108.29	51.90	17.30	22.75	2.56
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	95.70	20.15	4.48	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	122.91	38.52	12.98	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	60.81	58.16	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	148.14	17.99	8.11	4.59	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	127.14	27.61	5.81	4.36	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	85.85	23.25	9.27	4.55	0.17
Hepatocyte, donor1	11523-119I2	300.23	142.85	58.11	18.16	0.00
Hepatocyte, donor2	11603-120I1	136.82	100.19	20.47	10.77	1.08
Hepatocyte, donor3	11684-122I1	247.87	85.28	41.11	9.20	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	15.66	70.49	11.10	1.31	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	27.27	24.12	3.15	2.10	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	185.37	36.50	14.96	4.67	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	57.31	31.84	3.18	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	53.40	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	27.08	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	33.23	33.23	0.00	5.54	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	50.05	35.04	7.51	5.01	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	83.08	59.34	0.00	11.87	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	38.44	17.94	0.00	5.13	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	54.85	13.71	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	40.61	19.49	1.62	19.49	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	46.68	31.68	3.33	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	36.31	25.41	0.00	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	48.97	43.67	5.29	11.91	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	52.11	23.28	3.33	11.09	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	26.19	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	35.90	22.68	3.15	8.19	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	47.95	34.03	4.64	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	40.05	26.49	4.52	6.46	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	35.42	28.98	8.05	6.44	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	83.64	11.95	23.90	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	33.41	29.34	4.89	7.33	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	45.34	24.35	3.36	5.46	1.68
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	57.49	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	32.95	31.34	2.41	7.23	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	41.55	29.55	1.85	4.62	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	46.73	23.60	2.36	6.61	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	46.26	29.02	3.63	7.26	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	29.48	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	35.51	24.75	5.38	6.46	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	71.15	38.11	6.35	6.35	3.81
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	33.16	21.68	1.91	9.57	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	38.28	23.69	3.65	7.29	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	31.61	0.00	47.41	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	34.99	24.99	3.57	7.14	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	39.82	29.86	0.00	3.32	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	37.66	19.45	1.54	5.25	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	31.61	36.88	1.76	15.80	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	28.29	3.14	3.14	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	36.86	23.64	7.65	4.17	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	28.77	37.62	6.64	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	38.90	38.90	9.73	6.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	41.85	27.03	3.49	1.74	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	47.25	22.50	6.75	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	17.42	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	38.40	33.07	4.27	2.13	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	36.02	18.01	1.39	6.93	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	25.65	22.80	2.85	19.95	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	33.14	28.53	9.20	6.44	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	54.46	18.15	15.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	37.25	0.00	18.63	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	31.72	25.38	5.29	3.17	0.00
Keratinocyte - epidermal, donor1	11272-116H3	27.91	20.07	3.84	4.98	0.82
Keratinocyte - epidermal, donor2	11349-117G8	16.40	16.98	3.51	5.27	0.00
Keratinocyte - epidermal, donor3	11421-118F8	38.52	18.65	4.07	8.33	1.14
Keratinocyte - oral, donor1	11251-116E9	46.77	23.04	4.77	2.38	0.34
Keratocytes, donor1	11527-119I6	74.96	33.35	10.66	5.16	0.34
Keratocytes, donor2	11607-120I5	101.95	23.44	7.03	4.69	1.17
Keratocytes, donor3	11688-122I5	43.67	18.38	7.31	0.99	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	19.78	15.39	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	121.90	22.65	8.63	4.31	1.08
Lens Epithelial Cells, donor2	11609-120I7	115.68	23.18	7.73	1.85	0.00
Lens Epithelial Cells, donor3	11690-122I7	156.21	20.69	7.27	1.31	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	75.65	22.65	6.76	1.07	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	62.51	27.91	5.02	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	66.11	20.62	4.25	1.26	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	58.61	18.82	3.23	2.69	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	59.25	20.80	7.56	2.21	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	66.41	19.73	6.90	0.97	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	44.73	16.42	4.51	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	77.11	25.53	8.60	2.53	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	56.72	19.85	7.46	0.56	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	50.63	18.59	5.54	1.98	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	73.48	20.16	6.59	1.16	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	68.50	22.03	7.22	1.11	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	51.92	14.98	5.23	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	70.84	21.47	7.39	1.19	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	60.43	20.74	6.18	0.27	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	52.66	17.86	4.00	1.85	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	79.49	22.13	3.43	1.25	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	72.46	22.87	4.94	1.46	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	60.56	19.42	4.61	1.32	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	67.95	28.12	5.56	1.76	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	62.48	27.38	5.73	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	46.07	22.31	4.36	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	74.86	21.81	5.92	2.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	65.24	19.07	8.78	1.67	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	45.10	25.92	7.26	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	68.26	22.61	6.91	1.88	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	65.26	21.80	5.86	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	59.85	26.83	6.88	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	66.42	22.20	6.02	3.57	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	62.03	19.93	6.15	1.38	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	46.03	19.87	6.78	0.97	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	64.50	21.50	5.62	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	63.93	18.09	4.83	1.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	52.57	19.25	5.92	1.11	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	64.24	18.78	6.67	2.72	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	62.01	18.97	5.36	1.24	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	52.75	21.55	4.50	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	68.47	22.82	6.09	2.74	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	63.26	18.76	5.32	2.10	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	48.71	18.49	5.69	2.13	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	69.32	19.39	3.88	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	80.76	20.38	5.91	1.09	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	66.97	22.20	5.37	2.15	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	64.68	19.27	3.27	2.61	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	65.68	24.95	4.47	1.65	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	63.98	21.78	7.05	1.73	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	68.13	19.47	6.40	4.35	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	56.99	11.64	4.48	2.09	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	81.58	33.99	11.33	13.60	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	57.53	26.08	3.84	12.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	59.38	25.98	5.20	15.59	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	37.24	30.47	4.23	15.23	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	54.16	26.02	7.03	16.88	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	41.09	21.48	3.74	20.55	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	28.86	22.67	5.15	15.97	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	55.90	24.98	3.57	11.89	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	58.81	26.92	7.69	13.12	1.81
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	50.31	20.65	3.20	14.25	1.74
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	48.62	17.56	6.30	13.06	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	55.01	23.03	6.77	13.68	2.30
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	53.41	27.22	2.05	15.92	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	50.11	16.23	4.23	17.29	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	53.97	21.32	7.33	15.99	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	50.94	21.39	7.13	14.77	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	52.29	18.41	4.80	15.47	2.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	45.16	20.97	5.29	13.42	1.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	46.63	22.70	3.07	16.57	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	49.74	17.94	4.08	13.86	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	46.23	15.20	4.37	11.25	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	43.72	17.94	4.20	15.41	3.92
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	54.61	21.64	6.18	11.33	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	50.80	19.16	4.94	15.10	2.61
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	46.33	20.03	2.69	10.76	2.39
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	49.79	16.04	2.77	13.28	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	48.78	24.04	4.95	13.79	2.47
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	49.79	19.18	4.06	15.12	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	46.05	26.48	2.30	16.12	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	41.83	24.56	6.14	14.58	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	52.08	26.61	3.96	15.29	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	55.79	14.77	4.10	13.13	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	40.22	20.79	4.52	18.08	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	48.12	26.57	4.31	15.80	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	64.23	27.64	2.24	14.94	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	46.82	24.15	2.60	11.52	1.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	52.55	23.69	6.46	13.78	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	65.08	27.40	2.57	15.41	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	59.97	25.32	3.66	14.99	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	54.30	24.13	3.02	12.67	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	54.75	18.49	5.69	10.66	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	46.06	23.03	3.09	13.06	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	38.11	23.08	3.22	15.57	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	55.22	12.79	5.39	20.20	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	47.78	20.37	3.33	11.85	2.96
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	58.15	27.91	1.16	17.44	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	51.83	22.21	4.23	11.64	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	43.22	21.21	5.60	12.40	2.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	38.52	21.81	7.27	14.54	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	72.82	20.70	3.07	13.80	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	61.66	26.64	6.41	13.32	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	33.87	20.70	6.59	12.23	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	64.36	21.62	5.03	13.58	3.52
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	46.41	17.57	4.96	17.12	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	25.82	22.37	3.44	18.93	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	63.68	19.60	6.68	14.70	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	43.01	20.33	5.08	15.64	3.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	53.44	18.47	2.64	7.26	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	64.87	19.72	6.23	9.86	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	41.13	17.94	3.50	11.38	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	41.93	22.92	1.12	13.42	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	51.67	24.73	3.97	15.46	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	48.99	22.37	3.47	11.96	2.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	41.01	18.74	3.54	14.68	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	60.08	19.22	4.33	13.46	2.88
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	52.08	23.46	5.17	11.53	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	41.93	19.44	3.65	16.41	4.86
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	48.42	21.44	1.38	16.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	42.18	21.66	3.80	9.12	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	44.41	26.85	6.20	13.43	3.10
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	53.81	24.79	1.81	10.28	3.63
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	52.29	23.13	2.85	9.51	2.54
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	44.25	21.32	3.73	17.59	5.33
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	51.72	21.84	4.02	16.67	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	41.14	18.51	1.54	13.37	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	49.51	16.98	3.54	8.49	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	60.72	25.54	5.11	16.46	6.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	48.26	26.21	3.74	13.73	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	54.81	21.14	2.35	19.58	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	61.38	36.33	2.92	13.36	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	53.90	26.95	4.65	9.29	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	44.83	30.11	6.69	22.75	3.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	58.28	31.54	2.67	15.50	3.21
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	56.98	25.86	6.47	10.51	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	42.22	21.11	4.59	9.18	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	44.46	21.34	1.78	16.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	54.14	30.20	6.84	15.39	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	44.48	24.54	0.77	14.57	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	63.47	33.38	4.38	20.25	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	54.79	23.61	5.79	15.59	2.67
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	70.19	26.00	4.42	15.34	2.08
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	56.36	43.10	1.33	21.88	3.98
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	54.04	37.41	6.24	8.31	10.39
Macrophage - monocyte derived, donor1	11232-116C8	85.47	23.93	8.66	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	76.71	29.36	12.85	0.37	0.37
Macrophage - monocyte derived, donor3	11389-118C3	82.45	26.22	7.73	0.39	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	24.43	20.18	4.25	5.31	1.06
Mallassez-derived cells, donor2	11929-125I3	38.03	20.60	4.28	5.70	0.95
Mallassez-derived cells, donor3	11930-125I4	33.63	21.68	3.34	6.12	0.97
Mammary Epithelial Cell, donor1	11273-116H4	61.28	21.62	7.57	10.06	1.40
Mammary Epithelial Cell, donor2	11350-117G9	40.25	19.98	6.37	12.74	2.03
Mammary Epithelial Cell, donor3	11422-118F9	50.38	12.22	3.49	8.23	0.50
Mast cell - stimulated, donor1	11487-119E2	28.47	11.52	6.10	0.68	0.00
Mast cell, donor1	11563-120D6	43.15	29.74	3.57	0.00	0.00
Mast cell, donor2	11565-120D8	37.74	14.86	3.27	0.30	0.00
Mast cell, donor3	11566-120D9	46.60	22.06	3.38	0.90	0.00
Mast cell, donor4	11567-120E1	40.07	18.79	4.43	0.71	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	51.45	51.68	4.66	0.33	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	46.11	61.29	4.67	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	56.67	46.92	4.93	0.34	0.23
Mast cell, expanded, donor8	11941-126A6	50.04	49.37	3.51	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	109.95	29.65	7.26	1.09	0.50
Melanocyte - dark, donor2	11582-120F7	75.45	12.81	3.81	1.38	0.35
Melanocyte - dark, donor3	11663-122F7	86.20	54.98	19.85	0.29	0.07
Melanocyte - light, donor1	11274-116H5	58.30	29.15	11.75	0.00	0.00
Melanocyte - light, donor2	11351-117H1	63.47	36.17	8.19	0.00	0.00
Melanocyte - light, donor3	11423-118G1	63.31	22.55	7.81	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	83.40	62.68	22.49	0.73	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	102.20	66.16	15.87	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	77.95	57.59	11.79	1.07	0.00
Meningeal Cells, donor1	11493-119E8	153.21	40.44	8.06	6.20	1.12
Meningeal Cells, donor2	11573-120E7	141.73	21.13	7.92	3.08	1.32
Meningeal Cells, donor3	11654-122E7	110.84	41.24	11.08	6.11	1.14
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	149.42	32.22	13.12	1.43	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	189.69	39.05	13.18	1.51	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	572.98	80.16	35.48	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	146.51	31.40	14.39	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	162.90	59.56	16.50	4.31	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	119.23	23.93	6.78	1.69	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	103.04	20.11	5.53	2.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	127.46	42.41	13.40	1.54	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	106.67	47.49	16.80	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	118.26	35.81	13.91	3.07	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	276.46	32.69	8.17	2.77	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	156.87	30.11	7.43	2.60	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	157.10	25.26	5.79	2.11	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	190.80	32.94	8.01	2.67	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	88.75	14.01	16.35	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	131.92	26.26	7.68	2.56	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	152.41	46.08	15.60	2.48	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	159.49	22.20	3.44	0.94	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	102.32	31.20	10.16	6.53	0.73
Mesothelial Cells, donor1	11247-116E5	131.00	25.99	6.10	1.33	0.80
Mesothelial Cells, donor2	12156-128G5	126.12	27.53	6.51	3.00	0.00
Mesothelial Cells, donor3	11402-118D7	78.19	16.40	4.48	2.38	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	68.87	13.50	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	82.50	28.08	10.84	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	74.79	23.85	8.54	1.18	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	51.86	13.83	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	75.01	26.35	7.13	0.62	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	54.35	24.06	9.75	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	32.42	4.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	87.09	30.78	7.01	0.75	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	60.51	20.02	11.64	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	70.31	26.42	6.71	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	66.52	20.99	7.52	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	53.10	25.66	8.85	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	79.41	27.74	12.92	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	39.48	7.90	6.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	61.76	30.35	6.37	0.85	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	30.39	10.13	2.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	59.61	14.90	4.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	36.89	10.06	3.35	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	65.74	28.35	5.77	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	48.48	20.68	7.37	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	27.09	6.63	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	49.73	22.10	6.68	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	42.91	18.72	5.47	0.63	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	45.66	18.75	4.28	0.61	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	48.49	25.32	6.22	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	38.46	12.67	4.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	37.89	15.77	4.16	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	27.88	6.08	2.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	33.14	3.31	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	40.77	13.86	2.17	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	41.17	14.70	3.53	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	27.26	4.36	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	48.06	17.78	6.73	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	42.02	17.21	4.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	16.45	1.37	2.74	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	51.56	17.02	10.51	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	53.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	6.12	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	47.73	22.33	8.32	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	25.38	5.52	4.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	24.33	4.48	3.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	51.32	20.33	5.95	0.25	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	28.53	10.44	2.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	35.36	4.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	62.56	29.06	9.91	1.03	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	28.01	9.19	3.50	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	22.37	2.13	5.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	69.86	29.46	12.34	1.12	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	34.50	9.98	3.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	18.65	4.66	3.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	44.95	20.21	6.64	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	35.06	17.53	5.43	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	41.56	16.62	3.69	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	39.84	17.64	5.69	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	35.24	8.01	3.87	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	55.72	26.17	10.63	0.78	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	39.04	10.72	3.43	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	23.50	6.35	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	40.30	14.15	4.27	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	53.88	24.25	3.59	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	34.75	10.17	5.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	74.53	32.17	9.56	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	40.91	22.56	7.30	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	30.72	4.17	4.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	63.36	26.71	7.10	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	55.06	28.02	9.09	0.98	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	24.76	4.56	1.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	53.51	17.94	7.06	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	55.07	23.35	5.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	60.17	14.84	2.89	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	58.07	22.93	7.74	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	135.61	37.67	11.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	96.24	48.12	17.82	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	95.29	33.51	5.91	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	97.83	44.18	15.78	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	109.72	26.89	4.94	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	82.89	28.87	7.45	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	78.86	30.04	9.39	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	77.77	26.90	8.79	0.80	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	72.16	25.11	5.54	0.57	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	81.78	33.15	9.58	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	82.08	23.82	4.76	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	82.45	21.78	9.33	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	75.36	25.65	5.34	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	77.28	42.50	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	93.92	35.35	9.09	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	78.42	23.61	8.85	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	96.70	38.13	8.17	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	99.82	34.97	14.62	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	130.38	52.64	11.34	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	64.95	27.19	10.57	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	51.39	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	91.35	39.15	9.79	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	52.28	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	25.10	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	132.71	41.58	15.73	3.23	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	95.12	26.13	9.41	3.14	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	130.16	26.03	10.01	3.34	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	131.05	13.77	9.60	5.01	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	216.95	44.49	14.83	4.94	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	167.56	38.30	20.75	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	127.83	17.68	4.76	5.44	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	73.51	36.75	9.19	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	138.95	28.46	7.95	3.77	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	174.33	21.85	11.39	4.65	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	138.09	21.35	8.92	3.51	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	134.97	37.42	11.98	2.94	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	33.40	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	147.91	34.25	10.42	2.98	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	209.23	38.44	18.13	2.44	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	168.65	19.49	10.43	3.40	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	131.78	21.39	9.31	1.63	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	142.16	32.44	11.85	2.37	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	185.12	33.42	13.79	3.18	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	130.87	14.41	6.00	3.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	215.61	51.20	10.17	3.61	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	150.43	16.59	10.08	2.11	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	118.71	23.99	10.58	0.88	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	158.93	23.21	14.06	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	209.63	21.61	14.25	1.84	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	204.70	30.85	11.89	1.93	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	228.66	32.07	12.07	3.79	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	131.48	40.46	20.23	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	110.95	19.38	7.35	1.34	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	185.45	24.98	8.47	0.85	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	195.58	21.60	11.87	1.42	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	239.09	28.76	15.88	1.72	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	165.94	25.32	15.33	1.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	89.27	15.78	7.66	2.71	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	123.01	19.05	7.54	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	163.44	20.43	11.14	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	269.78	35.19	17.03	3.41	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	112.76	14.66	5.21	1.96	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	106.77	15.25	10.02	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	106.29	15.38	7.24	1.36	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	106.71	20.28	8.82	3.53	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	180.17	27.26	12.63	0.66	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	193.95	29.76	11.91	2.48	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	102.98	13.78	8.42	1.15	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	341.76	75.31	27.83	3.63	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	102.56	21.88	9.95	1.11	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	105.04	18.97	6.78	2.03	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	81.75	15.33	15.33	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	180.47	25.00	9.15	2.44	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	152.33	13.22	7.24	0.94	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	167.97	28.75	10.90	2.12	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	138.45	16.61	7.91	3.16	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	179.12	40.81	6.80	3.40	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	91.04	96.10	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	147.09	40.62	19.38	3.23	0.12
Myoblast, donor2	11322-117D8	141.54	35.10	14.58	3.26	0.19
Myoblast, donor3	11398-118D3	196.41	55.66	27.24	2.86	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	7.88	57.79	4.38	0.29	0.00
Natural Killer Cells, donor1	11230-116C6	5.84	38.13	0.92	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	3.02	26.54	1.21	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	4.42	25.40	0.74	0.55	0.18
Neural stem cells, donor1	11275-116H6	56.26	16.70	6.90	1.09	0.00
Neural stem cells, donor2	11352-117H2	30.81	32.74	5.78	0.00	0.00
Neurons, donor1	11494-119E9	19.34	71.69	9.10	0.00	0.00
Neurons, donor2	11574-120E8	36.55	68.91	10.13	0.22	0.44
Neurons, donor3	11655-122E8	27.13	57.55	13.15	0.82	0.00
Neutrophils, donor1	11233-116C9	0.00	19.49	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	2.90	49.28	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	3.05	29.93	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	141.77	24.46	7.84	1.19	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	168.01	28.33	8.14	3.58	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	147.41	22.86	5.21	2.21	0.00
Olfactory epithelial cells, donor1	11933-125I7	146.74	17.62	7.16	2.34	0.55
Olfactory epithelial cells, donor2	11934-125I8	139.82	22.00	11.15	3.33	0.87
Olfactory epithelial cells, donor3	11935-125I9	92.51	18.05	6.02	1.36	0.11
Olfactory epithelial cells, donor4	11936-126A1	176.48	35.26	9.45	3.12	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	85.46	24.07	2.41	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	273.52	55.94	21.91	1.70	0.43
Osteoblast - differentiated, donor2	11353-117H3	236.62	52.58	14.86	4.57	0.00
Osteoblast - differentiated, donor3	11425-118G3	124.14	34.14	17.38	1.86	0.62
Osteoblast, donor1	11277-116H8	145.01	26.38	10.55	2.74	0.20
Osteoblast, donor2	11354-117H4	98.32	27.39	9.13	4.21	0.70
Osteoblast, donor3	11426-118G4	172.40	40.70	18.13	6.04	0.53
Pancreatic stromal cells, donor1	11249-116E7	131.91	22.91	11.12	5.56	0.84
Pericytes, donor1	11491-119E6	269.49	70.54	19.92	3.34	0.78
Pericytes, donor2	11571-120E5	205.09	48.90	15.85	1.36	0.23
Pericytes, donor3	11652-122E5	297.85	44.15	22.79	6.92	0.41
Perineurial Cells, donor1	11499-119F5	267.07	56.28	21.59	5.65	0.90
Perineurial Cells, donor2	11579-120F4	99.46	10.77	4.78	1.38	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	15.94	23.27	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	14.20	17.14	1.22	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	11.39	22.65	1.29	0.26	0.00
Placental Epithelial Cells, donor1	11278-116H9	87.53	86.58	14.83	14.11	3.59
Placental Epithelial Cells, donor2	11355-117H5	109.78	72.08	13.31	11.09	2.22
Placental Epithelial Cells, donor3	11427-118G5	100.52	51.24	11.58	6.28	1.37
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	291.77	63.92	20.89	8.54	0.32
Preadipocyte - breast, donor1	11467-119B9	207.66	57.96	17.63	2.44	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	108.47	28.45	7.57	0.78	0.52
Preadipocyte - breast, donor2	11328-117E5	217.04	36.02	16.44	2.93	0.00
Preadipocyte - omental, donor1	11468-119C1	271.83	82.37	24.72	2.66	0.53
Preadipocyte - omental, donor2	11329-117E6	205.14	35.35	8.29	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	253.12	54.58	22.49	1.58	0.57
Preadipocyte - perirenal, donor1	11469-119C2	330.71	61.02	17.72	3.94	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	89.06	28.87	6.45	3.99	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	123.25	27.27	10.62	5.49	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	309.41	59.09	26.56	6.98	0.85
Preadipocyte - visceral, donor1	11280-116I2	152.48	39.40	12.76	7.08	1.40
Preadipocyte - visceral, donor2	11357-117H7	92.04	28.07	5.06	3.68	0.46
Preadipocyte - visceral, donor3	11429-118G7	166.24	31.24	12.85	7.63	1.36
Prostate Epithelial Cells (polarized), donor1	11253-116F2	30.02	15.54	5.58	2.87	0.75
Prostate Epithelial Cells, donor2	11331-117E8	48.75	16.93	5.42	5.01	0.81
Prostate Epithelial Cells, donor3	11404-118D9	10.53	16.90	4.53	1.10	0.12
Prostate Stromal Cells, donor1	11254-116F3	112.65	22.78	6.72	3.42	0.57
Prostate Stromal Cells, donor2	11332-117E9	121.21	26.36	11.83	2.87	0.90
Prostate Stromal Cells, donor3	11405-118E1	127.95	15.54	7.82	1.77	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	94.90	17.52	4.01	2.92	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	113.53	27.66	10.05	2.77	0.35
Renal Epithelial Cells, donor1	11517-119H5	151.15	40.07	9.13	12.68	1.01
Renal Epithelial Cells, donor2	11597-120H4	76.82	19.21	4.98	6.40	1.42
Renal Epithelial Cells, donor3	11678-122H4	110.73	31.87	8.58	2.65	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	124.60	25.19	8.85	4.09	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	110.10	34.90	6.87	2.43	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	64.61	14.21	4.88	3.11	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	129.10	59.22	12.64	2.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	146.14	30.15	9.24	6.16	0.88
Renal Mesangial Cells, donor2	11598-120H5	114.74	22.57	6.27	10.66	1.88
Renal Mesangial Cells, donor3	11679-122H5	150.36	21.92	6.94	4.44	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	78.38	14.49	5.64	4.29	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	57.77	8.43	3.37	3.37	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	103.94	16.58	5.98	7.14	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	97.75	30.34	8.04	0.26	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	89.25	15.92	5.97	0.28	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	120.41	36.02	9.26	4.12	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	50.18	31.87	11.54	1.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	81.79	38.62	7.62	2.41	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	143.84	60.75	22.34	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	102.37	53.39	13.21	2.20	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	98.61	62.65	13.92	1.74	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	127.16	52.40	12.48	2.34	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	120.46	48.06	15.89	2.09	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	142.77	65.59	19.18	2.79	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	113.38	55.32	14.02	2.23	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	134.73	58.27	20.98	1.98	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	139.60	56.40	19.18	3.00	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	98.16	44.63	11.91	0.96	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	103.32	48.71	16.49	2.27	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	137.80	57.88	18.99	1.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	115.63	59.82	13.34	2.44	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	121.59	52.69	16.31	3.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	128.56	53.77	17.92	1.99	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	81.06	46.07	8.41	2.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	101.73	43.97	15.47	1.68	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	127.96	63.70	18.41	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	101.52	36.49	13.27	2.26	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	119.05	43.71	16.16	2.34	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	124.51	54.23	20.24	1.91	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	109.68	46.99	10.57	2.24	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	112.96	47.93	17.38	2.52	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	116.55	49.56	17.09	1.03	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	97.55	47.04	11.67	0.73	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	119.69	47.34	17.41	1.96	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	127.74	57.49	18.13	1.75	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	104.49	70.29	9.91	2.12	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	120.64	49.21	16.47	1.59	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	125.58	49.81	19.18	3.04	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	108.65	59.30	16.59	2.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	93.35	50.21	15.04	3.32	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	114.47	45.75	16.50	2.51	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	111.44	50.47	12.92	1.88	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	92.13	35.25	12.77	2.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	112.40	44.73	15.23	0.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	95.08	61.55	13.24	3.27	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	101.37	35.53	14.81	2.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	104.90	46.13	15.92	0.82	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	91.52	50.79	11.76	2.39	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	128.43	50.31	14.20	1.78	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	94.09	35.98	10.93	1.33	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	113.10	40.37	9.54	1.66	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	129.53	48.81	15.48	2.62	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	128.78	46.96	12.70	2.02	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	119.79	49.25	12.34	1.41	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	97.82	50.31	17.82	2.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	69.81	26.90	14.20	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	149.56	70.62	13.22	2.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	93.88	40.61	14.85	2.47	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	117.43	62.06	21.90	1.83	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	143.77	68.72	10.55	4.82	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	159.01	73.06	21.04	2.04	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	179.42	93.16	25.46	2.10	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	143.81	69.78	15.70	1.65	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	197.44	88.58	28.82	3.42	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	170.68	76.93	23.44	1.20	0.00
Schwann Cells, donor1	11498-119F4	216.09	55.10	13.92	3.95	0.94
Schwann Cells, donor2	11578-120F3	88.46	54.44	10.21	6.80	0.00
Schwann Cells, donor3	11659-122F3	120.28	30.67	8.98	5.26	0.88
Sebocyte, donor1	11220-116B5	31.22	18.62	4.38	6.57	2.19
Sebocyte, donor2	11301-117B5	26.65	16.54	2.30	2.76	0.00
Sebocyte, donor3	11378-118B1	58.12	19.58	9.07	1.03	0.21
Sertoli Cells, donor1	11255-116F4	318.07	53.01	18.22	8.28	0.00
Sertoli Cells, donor2	11333-117F1	384.11	73.43	36.72	5.65	5.65
Skeletal Muscle Cells, donor1	11281-116I3	101.79	61.32	32.38	2.20	0.53
Skeletal Muscle Cells, donor2	11358-117H8	78.79	20.96	10.84	4.34	0.00
Skeletal Muscle Cells, donor3	11430-118G8	237.43	62.70	24.25	2.51	0.00
Skeletal Muscle Cells, donor4	11451-119A2	90.01	18.38	7.85	1.41	0.47
Skeletal Muscle Cells, donor5	11455-119A6	80.27	20.51	5.95	1.78	0.45
Skeletal Muscle Cells, donor6	11459-119B1	95.57	23.85	8.46	1.69	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	135.83	19.66	7.18	1.89	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	129.42	24.69	9.13	2.28	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	86.31	22.42	8.93	0.89	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	103.55	27.13	11.71	2.02	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	152.71	47.04	24.61	5.79	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	108.84	21.05	7.98	3.85	1.10
Skin - palm, donor1	10286-104F7	16.12	8.06	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	43.54	18.31	3.75	8.79	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	31.90	19.63	1.64	36.81	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	28.56	10.26	3.38	8.44	1.17
Small Airway Epithelial Cells, donor1	11256-116F5	34.47	18.07	3.89	5.98	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	18.99	6.61	2.95	2.95	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	37.64	10.57	3.59	12.69	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	23.01	10.42	2.47	2.85	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	137.32	66.65	20.06	12.03	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	589.84	96.27	35.57	4.67	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	142.84	32.92	11.17	2.94	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	95.69	23.65	7.29	0.22	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	164.60	37.02	11.81	5.91	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	159.15	32.45	10.82	3.86	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	98.07	14.01	4.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	155.57	32.47	14.77	2.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	259.34	47.88	27.93	4.43	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	229.56	42.51	25.48	4.74	0.90
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	140.98	23.12	12.37	3.58	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	176.60	25.69	12.40	1.18	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	110.19	9.40	4.27	1.71	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	142.18	35.95	12.36	2.60	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	66.37	11.87	3.65	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	156.84	26.01	11.37	1.77	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	67.33	18.36	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	152.11	38.15	10.01	4.77	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	107.95	20.35	6.93	1.92	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	94.92	14.21	6.24	2.37	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	90.89	15.85	7.03	2.73	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	174.01	40.22	18.72	3.09	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	201.56	30.18	17.25	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	115.36	22.12	7.77	3.59	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	125.29	18.78	9.22	3.41	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	120.31	15.86	6.05	1.33	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	261.16	77.80	32.91	3.12	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	145.41	31.40	15.47	2.05	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	209.52	40.46	13.28	6.04	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	68.35	26.23	7.42	1.85	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	132.63	21.70	7.19	1.20	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	145.00	26.67	11.14	2.63	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	240.73	23.59	15.22	2.03	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	140.07	28.65	12.66	2.71	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	178.54	36.01	18.00	2.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	56.86	15.51	2.58	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	234.86	59.53	21.39	3.72	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	197.91	46.45	14.64	6.06	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	168.61	31.65	11.60	2.51	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	104.13	31.27	7.37	2.06	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	87.97	20.24	7.91	1.42	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	104.18	13.55	6.54	1.40	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	161.33	39.87	18.42	3.31	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	139.97	28.30	14.79	4.33	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	165.47	26.51	8.46	3.57	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	114.03	23.62	8.66	1.68	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	131.04	20.03	6.95	1.01	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	186.19	58.57	14.76	0.48	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	142.39	36.70	18.84	3.91	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	219.84	30.49	7.73	2.87	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	155.94	32.48	14.34	2.93	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	167.73	28.57	11.47	0.78	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	167.93	41.25	13.75	6.61	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	135.39	36.82	10.79	5.95	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	163.86	47.79	11.50	1.44	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	103.62	37.76	11.92	4.26	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	95.32	25.21	9.45	4.73	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	205.19	41.65	15.74	3.81	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	230.41	33.14	10.38	2.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	163.86	34.69	10.87	2.93	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	158.13	26.58	11.92	3.21	0.00
Synoviocyte, donor1	11291-117A4	249.96	37.37	17.84	1.51	0.34
Synoviocyte, donor2	11368-117I9	221.93	37.72	21.29	2.18	0.17
Synoviocyte, donor3	11440-118H9	238.82	29.49	19.21	1.79	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	131.50	30.02	10.01	17.87	3.22
Trabecular Meshwork Cells, donor2	11612-122A1	107.03	27.75	5.95	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	131.06	22.69	5.79	7.41	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	44.01	21.36	5.16	4.66	0.93
Tracheal Epithelial Cells, donor2	11369-118A1	45.61	16.24	7.73	5.03	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	40.66	10.31	2.86	5.15	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	84.15	35.43	7.75	3.08	0.49
Urethra, donor2	10319-105A4	19.78	16.19	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	66.68	34.27	7.44	5.84	0.00
Urothelial Cells, donor2	11600-120H7	55.28	31.64	5.21	4.81	0.80
Urothelial Cells, donor3	11681-122H7	63.03	23.84	3.67	2.75	0.00
Urothelial cells, donor0	11216-116B1	65.31	28.31	3.34	1.11	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	18.69	64.95	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	10.01	68.62	1.43	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	14.37	39.02	2.74	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	12.05	46.49	2.75	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	8.72	51.13	1.74	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	16.66	55.19	2.08	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	21.11	58.74	1.84	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	14.61	40.17	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	81.91	18.50	6.54	4.44	0.86
Wilms' tumor cell line:HFWT	10597-108E3	18.48	8.80	8.80	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	26.54	10.33	2.23	8.94	1.96
achilles tendon, donor2	10292-104G4	22.73	4.13	10.33	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	7.90	66.03	3.82	0.76	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	39.01	35.52	8.82	2.32	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	27.18	114.91	6.29	5.70	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	29.12	97.42	15.78	1.36	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	39.07	58.18	8.99	2.81	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	142.12	90.30	31.09	2.33	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	40.29	66.42	6.53	8.98	2.18
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	43.62	31.73	7.05	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	111.48	78.81	13.07	1.23	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	53.59	34.56	10.48	1.94	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	42.50	56.12	9.20	3.68	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	27.30	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	55.31	29.74	9.30	2.32	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	36.51	55.66	11.39	1.29	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	37.70	26.01	7.89	1.17	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	40.43	17.20	6.51	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	68.27	55.52	16.45	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	50.34	18.72	2.46	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	75.10	25.60	8.53	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	79.46	24.57	7.58	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	71.49	26.24	6.02	0.72	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	39.42	51.45	8.69	2.67	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	27.68	15.01	7.67	1.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	35.31	11.15	5.57	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	23.35	25.24	5.65	1.13	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	37.07	19.63	3.93	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	41.24	20.62	7.50	5.62	0.00
adenocarcinoma cell line:IM95m	10796-110I4	20.25	6.12	1.18	8.95	1.65
adipose tissue, adult, pool1	10010-101C1	50.57	27.15	4.81	0.16	0.31
adipose, donor1	10184-103D4	90.31	31.08	9.97	2.93	0.59
adipose, donor2	10185-103D5	180.86	101.79	34.87	12.17	0.41
adipose, donor3	10186-103D6	72.70	37.58	9.80	4.90	1.91
adipose, donor4	10187-103D7	83.21	39.00	11.27	4.33	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	37.09	31.56	6.31	0.63	0.16
adrenal gland, adult, pool1	10081-102A9	40.01	32.74	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	58.30	45.36	5.74	3.34	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	78.61	16.79	6.07	3.22	0.71
amniotic membrane cells, donor1	12235-129G3	82.31	57.96	8.58	4.87	1.16
amniotic membrane cells, donor2	12236-129G4	179.87	74.04	9.47	7.78	2.03
amniotic membrane cells, donor3	12237-129G5	95.45	66.29	10.02	3.24	0.29
amygdala - adult, donor10196	10167-103B5	9.49	30.83	1.19	1.19	0.00
amygdala, adult, donor10252	10151-102I7	8.92	28.18	3.45	1.01	0.20
amygdala, newborn, donor10223	10360-105E9	10.97	25.18	3.23	1.29	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	69.78	15.92	5.60	2.04	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	48.54	26.92	5.29	3.75	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	50.44	6.35	7.68	6.01	1.00
aorta, adult, pool1	10052-101G7	103.17	24.71	7.45	1.57	0.20
appendix, adult	10189-103D9	29.89	28.33	5.05	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	74.98	33.02	7.57	7.22	2.41
artery, adult	10190-103E1	33.97	19.02	4.08	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	63.89	37.67	7.82	1.45	0.14
b cell line:RPMI1788	10427-106D4	31.38	42.38	2.97	2.53	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	344.59	75.19	42.17	1.94	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	21.63	10.32	2.78	1.89	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	8.70	15.90	3.51	0.84	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	40.27	22.37	6.71	0.00	0.00
bladder, adult, pool1	10011-101C2	73.77	32.48	4.89	0.54	0.33
blood, adult, pool1	10053-101G8	15.50	15.50	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	92.49	14.56	5.99	1.71	0.00
bone marrow, adult	10192-103E3	61.41	16.87	4.05	0.00	0.00
brain, adult, donor1	10084-102B3	31.78	32.80	9.23	2.05	0.00
brain, adult, pool1	10012-101C3	21.83	20.49	4.45	0.22	0.00
brain, fetal, pool1	10085-102B4	34.73	50.76	5.34	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	48.23	14.54	5.95	10.57	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	76.64	33.70	5.87	6.12	1.25
breast, adult, donor1	10080-102A8	56.82	29.67	1.26	2.53	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	38.62	16.90	3.68	15.24	1.78
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	39.58	7.11	2.47	3.40	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	158.62	46.96	6.91	1.38	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	30.02	11.86	3.15	16.46	2.91
carcinoid cell line:NCI-H1770	10703-109H1	70.53	72.41	10.81	6.11	1.41
carcinoid cell line:NCI-H727	10735-110B6	32.16	18.05	4.05	4.92	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	78.27	115.03	14.89	1.90	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	111.79	38.86	14.37	5.06	0.27
caudate nucleus - adult, donor10196	10177-103C6	13.82	25.33	3.45	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	11.38	22.42	2.68	0.50	0.17
caudate nucleus, adult, donor10258	10379-105H1	22.16	29.80	0.00	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	10.62	34.43	2.20	1.10	0.00
cerebellum - adult, donor10196	10173-103C2	34.96	17.48	0.00	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	18.15	38.65	3.84	4.06	0.64
cerebellum, adult, pool1	10083-102B2	27.94	18.97	5.17	2.41	0.00
cerebellum, newborn, donor10223	10357-105E6	25.74	58.95	4.98	4.15	1.66
cerebral meninges, adult	10188-103D8	27.74	21.68	4.29	0.50	0.00
cerebrospinal fluid, donor2	10294-104G6	12.43	7.31	2.19	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	134.58	104.53	52.19	21.57	3.59
cervical cancer cell line:ME-180	10553-107I4	12.10	22.70	2.98	3.81	1.33
cervix, adult, pool1	10013-101C4	91.55	28.87	4.83	1.26	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	136.83	32.33	9.61	0.42	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	103.19	10.45	9.14	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	50.08	13.30	4.97	14.42	4.23
choriocarcinoma cell line:SCH	10785-110H2	24.52	5.42	1.60	7.27	1.48
choriocarcinoma cell line:T3M-3	10618-108G6	32.02	6.64	2.61	14.23	2.37
chorionic membrane cells, donor1	12238-129G6	67.53	34.19	6.55	3.42	1.42
chorionic membrane cells, donor2	12239-129G7	150.54	32.22	9.15	1.29	0.30
chorionic membrane cells, donor3	12240-129G8	49.45	10.44	1.10	4.40	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	15.15	54.53	5.05	12.12	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	58.40	33.81	10.76	0.96	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	29.99	13.30	5.49	2.53	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	37.49	22.60	4.37	6.93	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	35.31	22.98	3.87	7.50	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	27.49	24.64	1.83	7.33	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	56.24	42.70	4.71	8.83	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	42.74	23.20	8.86	1.82	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	53.49	59.20	3.89	0.91	0.23
clear cell carcinoma cell line:TEN	10636-108I6	65.93	18.39	7.11	4.86	0.52
colon carcinoma cell line:CACO-2	10513-107D9	56.56	16.66	4.76	11.35	1.28
colon carcinoma cell line:COLO-320	10420-106C6	114.40	33.45	11.78	2.66	0.00
colon, adult, donor1	10082-102B1	49.98	26.18	1.19	4.76	0.00
colon, adult, pool1	10014-101C5	44.18	38.19	5.29	4.47	0.82
colon, fetal, donor1	10070-101I7	40.17	27.19	2.47	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	77.92	22.92	9.17	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	100.15	25.04	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	6.80	18.27	1.70	6.37	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	19.02	22.64	3.17	3.62	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	22.28	23.27	2.12	4.09	0.56
corpus callosum, adult, pool1	10042-101F6	45.33	44.56	11.94	0.33	0.00
cruciate ligament, donor2	10295-104G7	49.44	25.12	4.86	4.05	0.00
diaphragm, fetal, donor1	10069-101I6	59.39	24.88	3.21	0.80	0.00
diencephalon, adult	10193-103E4	15.60	23.76	3.84	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	9.41	47.76	2.53	2.30	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	19.49	10.51	2.82	3.85	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	62.59	29.13	10.83	2.41	0.24
ductus deferens, adult	10196-103E7	43.85	27.41	2.99	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	53.29	47.53	2.88	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	38.25	60.32	5.89	1.47	0.00
dura mater, adult, donor1	10041-101F5	79.78	21.14	5.20	1.16	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	34.87	47.08	10.44	15.77	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	62.76	46.86	11.18	12.47	1.00
embryonic pancreas cell line:1B2C6	10604-108F1	23.43	6.78	3.08	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	38.14	16.65	6.96	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	22.23	5.87	0.00	1.54	0.00
embryonic pancreas cell line:2C6	10603-108E9	26.27	5.25	3.94	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	83.13	13.74	3.35	2.01	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	79.74	39.15	16.31	0.91	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	32.16	17.69	4.02	9.97	0.64
epidermoid carcinoma cell line:A431	10426-106D3	24.57	10.23	3.00	4.11	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	31.46	15.40	5.28	10.34	1.10
epididymis, adult	10197-103E8	78.28	32.86	5.44	1.26	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	76.46	24.66	5.85	1.24	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	26.74	10.62	3.15	1.18	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	75.35	34.07	9.17	23.59	2.23
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	62.79	22.74	7.18	29.62	2.46
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	80.89	27.45	10.75	24.65	2.80
esophagus, adult, pool1	10015-101C6	38.44	29.20	3.82	0.21	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	55.10	29.05	7.51	3.51	0.63
eye - muscle inferior rectus, donor1	10272-104E2	12.07	14.49	4.83	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	23.15	6.31	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	28.28	7.44	2.98	0.00	1.49
eye - muscle superior, donor2	10297-104G9	34.39	8.03	5.73	3.44	0.00
eye - vitreous humor, donor1	10268-104D7	21.86	7.29	1.46	2.91	0.00
eye, fetal, donor1	10054-101G9	66.86	45.25	10.17	2.29	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	52.06	19.87	9.62	1.54	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	75.50	20.42	11.63	5.94	0.24
frontal lobe, adult, pool1	10040-101F4	19.70	25.43	4.50	0.28	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	40.83	22.22	3.30	4.80	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	91.99	35.11	7.41	0.27	0.09
gall bladder, adult	10198-103E9	59.63	29.94	3.86	2.41	0.24
gamma delta positive T cells, donor1	11937-126A2	9.13	117.57	3.22	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	11.95	89.64	2.24	1.12	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	30.84	13.31	3.38	4.01	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	28.24	17.21	5.03	1.74	0.58
gastric cancer cell line:AZ521	10549-107H9	60.83	24.27	4.10	0.49	0.00
gastric cancer cell line:GSS	10560-108A2	65.90	61.32	5.49	2.75	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	45.46	45.23	9.37	3.88	0.46
giant cell carcinoma cell line:LU65	10487-107B1	16.41	45.09	8.72	3.79	0.92
giant cell carcinoma cell line:Lu99B	10433-106E1	39.33	8.40	2.94	1.12	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	27.93	10.97	2.24	2.99	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	86.55	21.85	5.91	6.33	1.58
glioblastoma cell line:A172, tech_rep2	10444-106F3	105.33	21.91	5.76	4.35	1.26
glioblastoma cell line:T98G	10485-107A8	109.05	18.76	5.30	3.86	0.66
glioma cell line:GI-1	10413-106B8	127.99	21.97	8.49	2.64	0.59
globus pallidus - adult, donor10196	10175-103C4	22.60	28.43	2.19	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	16.60	36.13	6.10	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	27.38	31.49	6.85	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	16.52	36.24	2.13	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	95.44	29.37	17.13	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	153.00	109.28	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	188.16	120.21	47.04	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	138.56	26.24	7.68	2.88	0.64
hIPS +CCl2, biol_rep1	14383-156B9	42.70	34.89	7.35	6.89	1.84
hIPS +CCl2, biol_rep2	14384-156C1	26.52	44.35	7.32	8.23	0.91
hIPS +CCl2, biol_rep3	14385-156C2	44.44	33.49	9.02	8.37	0.00
hIPS, biol_rep1	14380-156B6	38.81	45.99	4.31	23.00	0.00
hIPS, biol_rep2	14381-156B7	50.07	42.52	8.92	12.35	2.06
hIPS, biol_rep3	14382-156B8	17.66	37.52	6.62	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	33.62	62.64	7.47	3.74	0.57
heart - mitral valve, adult	10205-103F7	61.59	19.73	4.78	0.90	0.00
heart - pulmonic valve, adult	10206-103F8	42.88	17.52	2.35	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	24.15	24.98	3.33	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	48.97	26.94	5.31	2.04	1.02
heart, adult, diseased, donor1	10051-101G6	37.47	39.18	5.96	0.00	0.00
heart, adult, pool1	10016-101C7	45.77	26.91	3.45	0.00	0.23
heart, fetal, pool1	10046-101G1	35.01	58.32	5.54	0.21	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	219.67	25.92	9.26	2.47	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	33.30	7.14	1.19	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	164.86	51.60	21.10	7.62	1.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	165.43	52.55	20.88	7.53	1.82
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	162.80	58.11	22.23	8.39	1.41
hepatoma cell line:Li-7	10484-107A7	23.58	14.24	3.78	1.89	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	48.04	19.40	8.14	2.41	0.20
hippocampus - adult, donor10196	10169-103B7	13.25	22.71	4.73	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	11.43	34.70	5.10	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	9.46	28.38	1.00	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	11.98	31.02	3.88	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	76.90	89.72	24.41	14.04	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	66.37	59.50	12.76	8.25	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	72.87	74.65	17.01	8.38	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	64.28	28.76	9.02	1.69	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	68.17	27.63	9.30	4.13	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	62.64	29.99	9.11	1.90	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	56.64	35.33	8.17	4.09	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	70.45	35.55	14.00	5.60	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	55.47	30.45	7.09	7.51	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	62.04	38.83	8.52	3.08	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	58.50	28.29	11.09	2.57	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	63.96	24.91	10.10	4.04	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	67.60	72.14	17.21	7.04	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	82.54	71.73	24.56	13.76	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	66.33	109.97	20.95	8.73	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	59.76	22.72	7.83	2.86	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	64.97	23.55	7.41	2.18	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	71.97	32.98	9.00	4.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	135.08	103.62	32.21	8.85	1.70
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	141.87	114.13	37.74	11.82	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	171.97	118.72	32.58	11.90	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	91.29	46.54	13.39	7.19	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	88.83	48.77	15.97	3.48	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	90.27	54.70	14.65	11.06	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	73.16	58.56	13.30	8.31	1.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	78.45	53.92	15.98	6.56	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	86.15	90.65	24.09	8.57	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	61.26	28.17	8.10	4.93	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	66.20	30.72	6.97	3.48	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	70.21	33.89	9.08	4.54	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	98.25	55.85	20.17	5.17	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	104.94	54.46	14.61	9.96	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	82.86	54.38	14.88	6.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	76.69	37.32	11.76	5.37	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	95.41	46.95	12.12	10.60	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	81.66	47.05	12.43	4.03	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	78.01	53.37	17.63	8.45	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	75.32	80.22	20.95	9.80	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	75.61	69.27	20.49	5.37	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	61.73	30.26	7.03	3.06	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	29.28	26.03	0.00	9.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	71.48	38.72	8.94	3.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	76.07	54.73	15.87	3.83	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	86.85	48.49	15.56	5.43	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	70.82	56.23	15.66	5.69	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	50.12	38.19	7.16	5.97	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	70.42	34.67	11.51	5.42	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	64.65	37.45	10.78	4.58	0.27
immature langerhans cells, donor1	11904-125F5	34.14	8.72	1.94	5.57	0.48
immature langerhans cells, donor2	11905-125F6	35.65	7.13	3.96	0.79	1.58
insula, adult, pool1	10039-101F3	20.44	31.70	5.39	0.66	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	48.45	26.34	5.53	5.85	0.65
kidney, adult, pool1	10017-101C8	87.41	30.74	7.31	3.50	0.80
kidney, fetal, pool1	10045-101F9	62.60	56.52	8.42	1.27	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	65.90	23.29	8.24	1.28	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	79.07	32.90	14.24	3.59	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	18.53	7.89	4.04	9.54	1.47
left atrium, adult, donor1	10079-102A7	46.86	14.71	1.09	0.00	0.00
left ventricle, adult, donor1	10078-102A6	30.84	16.69	3.03	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	120.11	18.33	10.12	2.74	0.55
leiomyoma cell line:10964C	10569-108B2	186.09	62.51	18.32	3.23	0.00
leiomyoma cell line:15242A	10570-108B3	196.20	58.15	17.93	6.52	0.00
leiomyoma cell line:15425	10571-108B4	190.61	64.35	19.91	3.89	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	336.52	114.29	38.10	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	29.28	7.32	0.00	4.18	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	34.00	23.85	8.74	1.42	0.59
liposarcoma cell line:KMLS-1	10782-110G8	213.07	56.70	29.37	4.53	1.41
liposarcoma cell line:SW 872	10726-110A6	95.03	17.91	3.90	5.12	0.85
liver, adult, pool1	10018-101C9	316.02	176.65	67.90	8.43	2.11
liver, fetal, pool1	10086-102B5	87.49	38.57	15.05	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	16.77	19.54	4.08	0.15	0.00
locus coeruleus, adult, donor10252	10165-103B3	13.10	32.67	5.17	0.55	0.18
locus coeruleus, adult, donor10258	10375-105G6	25.67	31.04	5.92	1.69	0.00
locus coeruleus, newborn, donor10223	10362-105F2	13.04	28.60	3.36	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	42.63	8.86	3.46	1.52	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	31.71	9.65	0.69	0.69	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	65.12	13.97	4.35	1.71	0.26
lung, adult, pool1	10019-101D1	50.32	29.53	4.13	0.24	0.12
lung, fetal, donor1	10068-101I5	33.96	65.93	2.85	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	47.20	25.20	5.04	0.46	0.00
lymph node, adult, donor1	10077-102A5	34.56	21.30	2.37	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	68.16	66.85	6.14	3.73	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	1.66	41.50	1.51	0.45	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	11.89	8.49	0.00	3.40	0.00
mature adipocyte, donor1	12231-129F8	72.37	20.87	1.78	0.00	0.00
mature adipocyte, donor2	12232-129F9	74.71	23.24	3.74	0.83	0.00
mature adipocyte, donor3	12233-129G1	67.09	16.59	3.56	0.24	0.00
mature adipocyte, donor4	12234-129G2	66.07	22.37	5.26	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	43.60	41.70	8.58	9.53	1.67
medial frontal gyrus - adult, donor10196	10170-103B8	9.02	13.54	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	11.59	26.67	1.66	0.18	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	16.20	27.64	1.91	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	7.68	30.71	3.41	2.56	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	15.36	22.78	2.19	1.35	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	10.19	29.07	2.55	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	38.53	1.93	7.71	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	9.69	30.15	3.23	0.72	0.00
medulla oblongata - adult, donor10196	10174-103C3	31.15	19.47	3.24	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	17.96	34.37	4.02	0.31	0.00
medulla oblongata, adult, pool1	10038-101F2	29.22	30.94	5.47	0.65	0.16
medulla oblongata, newborn, donor10223	10361-105F1	17.01	36.80	5.21	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	57.35	71.07	31.00	4.43	0.00
medulloblastoma cell line:ONS-76	10759-110E3	56.49	16.02	6.60	12.72	1.47
melanoma cell line:COLO 679	10514-107E1	45.57	23.29	5.46	1.01	0.00
melanoma cell line:G-361	10465-106H6	55.11	36.92	16.02	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	36.90	18.63	3.80	1.63	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	69.61	89.00	22.91	88.12	9.69
merkel cell carcinoma cell line:MS-1	10844-111E7	47.44	63.25	9.85	51.07	6.74
mesenchymal precursor cell - adipose, donor1	11747-123G1	242.27	51.09	18.87	4.45	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	179.60	28.90	11.82	1.64	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	207.88	75.78	16.98	4.56	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	225.18	41.02	14.61	0.56	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	318.32	61.81	18.49	2.50	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	517.09	214.47	79.82	5.55	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	183.31	37.93	14.93	2.23	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	159.87	31.51	9.89	1.04	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	125.08	27.59	8.75	3.32	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	134.91	36.73	10.13	3.11	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	143.69	28.31	9.10	1.85	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	79.70	19.10	6.92	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	171.03	26.84	10.38	2.21	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	214.34	84.83	25.83	5.59	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	345.65	66.97	24.50	1.02	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	145.94	34.51	11.50	1.44	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	236.38	42.41	10.14	2.28	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	129.04	32.37	11.40	2.51	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	112.86	56.22	13.85	5.03	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	186.05	41.39	8.82	1.64	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	129.81	19.87	7.00	2.80	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	239.67	63.32	12.15	2.21	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	190.29	46.07	14.31	4.01	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	181.04	67.36	32.00	4.63	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	165.77	34.71	14.16	2.74	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	153.47	37.09	11.77	3.58	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	165.69	36.38	17.80	3.66	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	163.59	36.35	14.79	4.01	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	148.74	28.01	17.89	4.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	151.63	38.25	16.92	5.08	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	133.61	38.12	15.33	3.54	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	115.85	31.97	16.68	4.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	158.63	40.67	15.29	5.77	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	141.45	35.92	14.50	3.12	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	155.27	31.73	15.62	3.61	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	130.53	18.33	13.93	3.67	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	135.61	36.59	17.12	3.69	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	144.51	43.80	16.38	4.50	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	143.90	30.93	14.18	6.44	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	142.19	30.08	13.67	10.94	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	154.95	56.81	25.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	162.07	34.10	14.29	6.17	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	199.33	48.01	13.09	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	211.63	39.45	22.92	5.86	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	177.46	35.98	14.72	3.27	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	167.93	32.26	14.77	3.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	163.70	52.47	10.49	6.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	166.90	51.66	16.89	4.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	162.09	33.37	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	176.11	34.39	12.45	1.78	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	168.15	30.46	10.97	3.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	81.16	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	164.68	33.57	14.57	4.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	177.28	35.87	15.18	3.10	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	167.64	34.39	10.75	6.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	227.53	35.93	3.99	7.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	203.19	61.99	10.33	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	224.11	44.01	19.15	2.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	236.74	45.28	21.45	6.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	235.81	44.21	23.58	2.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	205.41	44.89	16.83	2.81	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	266.00	52.13	21.39	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	189.23	33.11	15.37	3.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	215.71	35.95	7.70	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	203.77	40.62	15.14	2.07	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	115.29	25.24	10.89	2.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	100.94	30.28	8.97	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	114.49	26.71	11.45	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	120.49	38.69	7.66	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	128.65	28.35	8.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	117.84	35.48	12.67	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	41.88	13.35	4.25	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	67.78	4.52	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	54.36	13.18	5.77	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	248.03	44.65	11.91	1.59	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	182.04	30.50	12.98	1.30	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	212.89	29.54	12.22	4.07	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	86.66	12.38	6.96	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	107.02	27.64	6.61	4.02	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	31.04	12.74	1.16	2.55	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	51.28	38.46	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	114.67	54.97	12.43	2.57	0.41
mesothelioma cell line:Mero-25	10850-111F4	44.48	48.34	9.53	9.08	1.13
mesothelioma cell line:Mero-41	10851-111F5	90.46	19.80	5.62	9.53	0.98
mesothelioma cell line:Mero-48a	10852-111F6	83.92	23.69	5.09	8.41	2.66
mesothelioma cell line:Mero-82	10853-111F7	34.69	11.56	4.73	11.83	0.53
mesothelioma cell line:Mero-83	10854-111F8	44.26	18.38	3.74	3.57	0.51
mesothelioma cell line:Mero-84	10855-111F9	34.38	10.11	2.27	4.04	0.51
mesothelioma cell line:Mero-95	10856-111G1	66.67	18.43	3.73	14.49	2.69
mesothelioma cell line:NCI-H2052	10847-111F1	41.41	18.22	6.79	4.80	0.66
mesothelioma cell line:NCI-H226	10846-111E9	26.61	5.25	1.09	9.05	1.81
mesothelioma cell line:NCI-H2452	10848-111F2	58.59	16.06	3.59	3.25	0.51
mesothelioma cell line:NCI-H28	10845-111E8	90.84	26.72	6.62	1.78	1.02
mesothelioma cell line:No36	10857-111G2	48.93	30.34	6.52	3.91	0.33
mesothelioma cell line:ONE58	10858-111G3	32.51	7.32	1.35	2.17	0.54
migratory langerhans cells, donor1	11901-125F2	30.13	27.64	1.73	4.80	0.38
migratory langerhans cells, donor2	11902-125F3	24.30	29.43	2.69	2.69	0.24
migratory langerhans cells, donor3	11903-125F4	36.79	24.05	1.79	5.38	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	57.79	24.49	5.55	2.94	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	197.74	29.67	16.53	6.15	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	11.98	2.53	2.07	3.92	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	25.88	17.51	1.90	1.14	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	70.04	64.31	23.84	0.74	0.00
myeloma cell line:PCM6	10474-106I6	45.46	46.65	6.72	0.99	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	64.93	14.71	4.57	3.04	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	98.27	27.66	10.00	7.85	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	16.49	23.40	6.80	1.56	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	16.47	32.95	6.84	1.47	0.37
nasal epithelial cells, donor2	12227-129F4	36.43	15.46	3.31	6.07	0.55
neuroblastoma cell line:CHP-134	10508-107D4	53.37	49.46	23.01	2.99	1.38
neuroblastoma cell line:NB-1	10539-107G8	89.99	58.37	16.84	8.04	2.43
neuroblastoma cell line:NBsusSR	10607-108F4	23.41	39.23	10.97	6.12	0.84
neuroblastoma cell line:NH-12	10555-107I6	65.22	57.77	20.68	4.47	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	18.98	45.78	13.28	0.71	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	30.88	81.88	12.04	0.95	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	51.93	27.98	9.46	0.60	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	15.89	49.59	5.72	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	123.50	20.76	9.58	6.65	1.06
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	37.88	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	59.70	43.97	5.58	2.03	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	140.89	151.30	8.01	11.21	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	240.13	40.40	16.03	5.45	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	125.86	27.59	9.46	1.84	0.26
nucleus accumbens, adult, pool1	10037-101F1	17.53	24.56	3.56	1.12	0.28
occipital cortex - adult, donor10196	10172-103C1	8.24	32.97	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	11.54	35.16	3.49	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	9.83	37.49	4.00	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	22.57	33.59	3.67	0.52	0.00
occipital lobe, fetal, donor1	10073-102A1	15.02	39.48	7.72	0.86	0.00
occipital pole, adult, pool1	10036-101E9	18.13	29.57	5.99	0.55	0.08
olfactory region, adult	10195-103E6	14.52	21.40	3.25	0.57	0.00
optic nerve, donor1	10277-104E7	50.03	36.02	12.01	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	18.45	11.28	3.87	5.58	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	37.09	11.27	4.53	4.53	1.10
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	12.36	10.16	2.03	3.39	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	14.55	3.00	1.27	3.23	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	130.23	27.63	11.76	1.76	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	51.39	10.28	4.67	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	69.34	17.18	7.85	0.85	0.00
ovary, adult, pool1	10020-101D2	68.66	26.64	6.90	0.70	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	131.44	24.56	16.68	5.50	0.55
pancreas, adult, donor1	10049-101G4	162.73	39.51	7.53	3.76	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	23.48	10.62	0.56	17.61	5.31
papillary adenocarcinoma cell line:8505C	10437-106E5	38.16	17.38	6.13	2.56	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	30.14	14.07	1.16	0.66	0.00
paracentral gyrus, adult, pool1	10035-101E8	20.68	26.72	4.21	0.55	0.09
parietal cortex, adult, donor10258	10373-105G4	12.48	22.75	4.40	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	14.11	26.33	3.76	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	9.41	29.36	2.57	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	23.44	28.11	3.61	0.35	0.09
parietal lobe, fetal, donor1	10072-101I9	10.67	50.43	8.73	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	9.72	31.40	3.74	0.75	0.37
parotid gland, adult	10199-103F1	79.55	49.33	4.32	2.47	0.00
penis, adult	10200-103F2	35.45	23.10	4.30	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	18.22	73.63	12.09	1.12	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	39.48	16.17	3.21	4.23	0.73
pineal gland - adult, donor10196	10179-103C8	21.93	54.83	14.19	1.94	0.00
pineal gland, adult, donor10252	10160-103A7	27.83	82.32	18.95	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	31.35	84.03	11.29	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	95.11	44.52	8.09	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	76.09	55.25	7.30	1.04	0.00
pituitary gland, adult, donor10258	10378-105G9	115.77	69.80	5.96	5.11	0.00
placenta, adult, pool1	10021-101D3	49.45	31.61	6.56	0.75	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	18.14	51.78	3.84	0.66	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	178.52	32.84	7.16	2.96	1.25
pons, adult, pool1	10033-101E6	25.39	29.61	6.46	0.43	0.17
postcentral gyrus, adult, pool1	10032-101E5	19.53	29.81	4.36	0.17	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	294.89	31.37	12.55	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	291.93	55.08	33.05	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	340.34	58.68	46.94	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	148.72	21.41	10.49	6.85	1.89
prostate cancer cell line:PC-3	10439-106E7	103.46	28.86	9.44	11.07	2.36
prostate, adult, pool1	10022-101D4	58.86	33.28	4.72	0.45	0.18
putamen, adult, donor10196	10176-103C5	12.04	16.52	2.36	0.47	0.00
putamen, adult, donor10252	10152-102I8	17.65	68.63	7.84	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	17.48	39.34	4.37	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	12.81	26.34	3.62	0.72	0.24
putamen, newborn, donor10223	10365-105F5	9.75	39.73	3.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	14.55	6.11	2.62	2.62	0.58
rectum, fetal, donor1	10067-101I4	34.77	50.08	4.17	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	153.91	22.68	5.09	4.24	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	361.61	126.75	38.11	13.67	2.49
retina, adult, pool1	10030-101E3	60.53	43.44	7.55	0.99	0.20
retinoblastoma cell line:Y79	10475-106I7	87.81	93.27	24.94	11.17	3.12
rhabdomyosarcoma cell line:KYM-1	10787-110H4	72.29	17.95	4.55	5.78	1.72
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	28.68	10.40	3.66	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	122.01	15.16	9.09	0.00	0.00
salivary acinar cells, donor1	11771-123I7	33.50	15.70	5.50	4.21	0.00
salivary acinar cells, donor2	11772-123I8	42.68	16.11	7.16	3.99	1.10
salivary acinar cells, donor3	11773-123I9	23.83	12.58	1.32	1.99	0.00
salivary gland, adult, pool1	10093-102C3	108.10	67.49	9.72	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	40.64	13.32	4.38	1.52	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	45.38	12.23	5.88	0.82	0.35
seminal vesicle, adult	10201-103F3	62.96	18.52	2.65	1.59	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	37.65	12.63	2.67	4.86	1.70
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	89.08	25.16	7.80	5.03	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	60.21	31.11	8.03	2.01	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	30.36	4.03	2.01	1.61	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	20.01	10.28	3.21	5.97	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	17.55	10.71	1.68	2.06	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	10.64	6.38	2.13	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	26.51	16.19	3.96	0.24	0.36
skeletal muscle, fetal, donor1	10066-101I3	83.42	26.13	4.02	1.01	0.00
skin, adult, donor1	10074-102A2	61.07	27.14	13.57	6.79	0.00
skin, fetal, donor1	10065-101I2	65.65	36.61	5.68	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	58.37	33.02	5.34	52.03	5.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	54.53	45.39	9.46	12.61	2.84
small cell lung carcinoma cell line:DMS 144	10841-111E4	36.81	87.31	8.67	0.96	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	7.75	5.93	0.66	11.37	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	48.42	114.36	18.34	3.70	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	64.94	26.80	7.63	15.25	1.09
small intestine, adult, pool1	10024-101D6	56.02	60.80	8.12	15.17	2.51
small intestine, fetal, donor1	10064-101I1	15.72	33.91	1.72	0.25	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	107.20	90.78	12.82	8.72	0.51
smooth muscle, adult, pool1	10048-101G3	71.08	23.52	6.20	0.78	0.26
somatostatinoma cell line:QGP-1	10781-110G7	40.74	19.03	6.70	9.65	1.34
spinal cord - adult, donor10196	10181-103D1	30.28	21.79	5.28	0.92	0.00
spinal cord, adult, donor10252	10159-103A6	20.50	26.81	4.73	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	24.21	33.90	3.46	2.08	0.00
spinal cord, fetal, donor1	10056-101H2	91.48	73.79	10.37	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	25.72	51.43	5.05	2.76	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	157.12	24.94	12.84	2.99	0.60
spleen, adult, pool1	10025-101D7	25.33	34.58	2.86	0.00	0.00
spleen, fetal, pool1	10044-101F8	27.25	44.89	2.70	0.08	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	31.99	45.86	4.87	3.83	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	10.06	7.78	1.33	1.71	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	51.37	31.45	5.94	3.49	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	33.62	16.42	4.69	9.77	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	30.17	40.97	13.84	4.61	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	57.19	97.85	16.94	37.28	5.51
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	54.58	10.15	2.12	2.12	0.00
stomach, fetal, donor1	10062-101H8	51.26	11.75	1.07	3.20	0.00
submaxillary gland, adult	10202-103F4	87.16	39.31	6.27	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	24.51	40.50	7.69	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	12.41	23.79	3.62	1.55	0.00
substantia nigra, newborn, donor10223	10358-105E7	24.73	45.22	4.24	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	77.95	53.65	8.25	3.21	1.38
temporal lobe, adult, pool1	10031-101E4	25.86	30.94	4.75	0.51	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	22.08	61.25	6.41	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	17.58	61.10	7.91	1.32	0.44
tenocyte, donor1	11763-123H8	299.18	61.79	23.74	5.59	1.05
tenocyte, donor2	11765-123I1	321.99	70.58	26.32	4.58	0.00
tenocyte, donor3	11768-123I4	353.61	85.25	41.51	12.97	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	30.93	20.06	6.97	27.19	3.91
teratocarcinoma cell line:NCR-G1	10798-110I6	57.81	20.04	7.24	0.77	0.00
teratocarcinoma cell line:PA-1	10807-111A6	57.96	24.02	11.16	5.73	1.70
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	29.20	8.25	2.29	14.98	3.05
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	18.53	15.13	2.27	7.94	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	12.11	9.82	1.74	6.22	1.53
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	23.12	18.24	4.56	12.38	0.98
testis, adult, pool1	10026-101D8	74.62	35.76	7.84	0.64	0.00
testis, adult, pool2	10096-102C6	60.45	53.23	9.92	2.71	0.45
thalamus - adult, donor10196	10168-103B6	20.98	29.81	8.83	1.10	0.00
thalamus, adult, donor10252	10154-103A1	17.19	35.95	6.72	0.00	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	13.86	38.49	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	21.90	22.23	4.78	1.32	0.33
thalamus, newborn, donor10223	10366-105F6	12.66	16.68	2.30	2.30	0.58
throat, adult	10209-103G2	40.70	20.22	3.00	1.50	0.00
throat, fetal, donor1	10061-101H7	36.26	28.95	2.13	0.91	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	69.75	177.47	26.63	12.32	1.99
thymus, adult, pool1	10027-101D9	9.05	59.85	2.39	0.60	0.20
thymus, fetal, pool1	10043-101F7	17.04	57.36	2.81	0.62	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	71.13	10.11	8.11	13.69	1.33
thyroid carcinoma cell line:TCO-1	10783-110G9	72.78	16.90	6.98	7.26	0.00
thyroid, adult, pool1	10028-101E1	79.41	39.28	3.73	0.65	0.28
thyroid, fetal, donor1	10060-101H6	58.27	24.78	4.22	1.05	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	26.51	19.54	4.42	1.16	0.00
tongue, fetal, donor1	10059-101H5	39.41	30.74	3.94	0.39	0.39
tonsil, adult, pool1	10047-101G2	30.05	40.27	4.51	0.60	0.30
trachea, adult, pool1	10029-101E2	43.03	30.10	4.01	1.31	0.25
trachea, fetal, donor1	10058-101H4	75.02	35.01	5.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	94.59	15.59	5.67	1.77	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	19.66	11.14	3.34	7.80	1.11
transitional-cell carcinoma cell line:JMSU1	10492-107B6	389.84	108.90	43.09	7.83	0.78
tridermal teratoma cell line:HGRT	10694-109G1	127.47	7.61	1.90	5.71	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	26.07	10.50	3.22	2.62	0.25
umbilical cord, fetal, donor1	10057-101H3	73.03	45.90	8.35	2.09	0.00
uterus, adult, pool1	10100-102D1	86.68	35.32	4.44	1.37	0.00
uterus, fetal, donor1	10055-101H1	78.84	48.63	5.63	1.54	0.00
vagina, adult	10204-103F6	31.66	20.68	5.82	0.00	0.00
vein, adult	10191-103E2	30.47	34.63	4.16	0.66	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	22.70	20.56	3.20	2.14	0.00